Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 28, 2025
Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight
GlobeNewswire
·
April 28, 2025
New York, USA, April 28, 2025 (GLOBE NEWSWIRE) -- Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use …
Best NAD+ Supplement for Anti Aging and Brain Health 2025 - Top NMN Supplements and NAD Booster Pills for Longevity
GlobeNewswire
·
April 28, 2025
Glasgow, United Kingdom, April 28, 2025 (GLOBE NEWSWIRE) -- Looking to stay sharp, energized, and youthful? NAD+ supplements have become the best solution for fighting aging, boosting brain health, and increasing cellular energy. Nicotinamide Adenine …
Volume Pills Under Reviews: Does This Semen Volume Booster Pills Works? Top Sperm Enhancer
GlobeNewswire
·
April 28, 2025
Elizabethton, Tennessee, April 28, 2025 (GLOBE NEWSWIRE) -- When it comes to reproduction, in the cases of males, most of us are mistaken that Ameil’s performance is the only reason behind infertility. However, a lot of factors contribute to male fertility …
Best NAD+ Supplements: GenuinePurity Liposomal NAD For Anti-Aging & Longevity - Tested & Reviewed
GlobeNewswire
·
April 28, 2025
Albany, New York, April 28, 2025 (GLOBE NEWSWIRE) -- At least over the last decade, there have been a lot of advancements in the health sector. The supplement market especially is booming with innovative solutions such as capsules, tablets, powder, …
MITOLYN REVIEWS: Does It Really Work for Weight Loss or Is It a Scam?
GlobeNewswire
·
April 28, 2025
New York City, April 28, 2025 (GLOBE NEWSWIRE) -- a very potent dietary supplement, Mitolyn was developed specifically for the purpose of promoting weight loss and general well-being. By regulating hormone levels and bolstering the immune system with its …
Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares
GlobeNewswire
·
April 28, 2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 28 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in …
Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th
GlobeNewswire
·
April 28, 2025
Shared data underpins key advanced trials in hepatic encephalopathy, acute-on-chronic liver failure (ACLF) and decompensated cirrhosis Management attending conference LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Yaqrit, a late clinical-stage company …
ZEISS fördert den Einsatz von Spatial Biology-Analytik in der klinischen Forschung
GlobeNewswire
·
April 28, 2025
Der Gewebeschnitt-Scanner ZEISS Axioscan 7 spatial biology erlaubt skalierbare Workflow-Automatisierung - Umfassendes Lösungsportfolio für die Herausforderungen in der klinischen Forschung – von Färbereagenzien für Multiplex-Immunfluoreszenz (mIF) zu …
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
GlobeNewswire
·
April 28, 2025
Company is advancing portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Lead candidate JADE-001 on track to enter the clinic in second half of 2025, with initial data expected in first half of 2026 …
Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025
GlobeNewswire
·
April 28, 2025
– CHS-114 demonstrates clinical efficacy and proof of mechanism in HNSCC in combination with toripalimab – – Confirmed partial response in heavily pretreated PD-1 refractory patient supports expansion in HNSCC and gastric cancer in combination with …
A New Name. A Global Mission. Introducing SafeSpace Global Corporation
GlobeNewswire
·
April 28, 2025
Knoxville, TN, April 28, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies is proud to announce a major milestone in its evolution: the Company has officially rebranded as SafeSpace Global Corporation (OTC PINK: SSGC). This transformation …
Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France
GlobeNewswire
·
April 28, 2025
MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M…
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
GlobeNewswire
·
April 28, 2025
WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by IRADIMED CORPORATION (NASDAQ: IRMD), please note that in the first paragraph the date of the earnings call should read "Monday, May 5, …
Boehringer’s new zongertinib data demonstrate durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC
GlobeNewswire
·
April 28, 2025
Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC). The data were featured in the official press …
VIDEO: California Firefighter ‘Living the Best of These Last Months’ on Hospice Care
GlobeNewswire
·
April 28, 2025
IRVINE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- “Hospice is not something that means death right away. It means health and happiness,” said Debbie Forrester, spouse and patient caregiver for former firefighter Jim Forrester of Orange County, California. …
PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry
GlobeNewswire
·
April 28, 2025
MENLO PARK, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced it plans to improve on its already highly accurate methylation detection capabilities in …
VitalHub Announces Q1 2025 Conference Call Date
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it will release its financial results for its first quarter 2025 ended March 31, 2025, after market close on May …
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
GlobeNewswire
·
April 28, 2025
JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that it has successfully closed a …
LogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic Goals
GlobeNewswire
·
April 28, 2025
LOUISVILLE, Ky., April 28, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK) (the “Company”), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing care economy, today announced changes …
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
GlobeNewswire
·
April 28, 2025
$25 Million Funded at Close to Refinance Existing Debt and Extend Maturity Additional Borrowing Capacity Provides Minimally Dilutive Growth Capital CARLSBAD, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of …